Detecting bacterial contamination in platelet products

Clinical Laboratory

Volumn 52, Issue 9-10, 2006, Pages 443-456

  Palavecino, Elizabeth L ^a   Yomtovian, Roslyn A ^b   Jacobs, Michael R ^b,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE;

BACTEREMIA; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD BANK; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION REACTION; CLINICAL LABORATORY; CORRELATION ANALYSIS; FEASIBILITY STUDY; FOOD AND DRUG ADMINISTRATION; GRAM STAINING; HUMAN; IMMUNE RESPONSE; INFECTION; INOCULATION; MEDICAL SOCIETY; METHODOLOGY; NONHUMAN; PATHOLOGY; PATIENT CARE; PHYSICIAN; PREDICTION; PROCESS DEVELOPMENT; PROFESSIONAL STANDARD; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEPSIS; SPECIES; THROMBOCYTE TRANSFUSION;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD PLATELETS; HUMANS; PLATELET TRANSFUSION; QUALITY CONTROL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

BACTERIA (MICROORGANISMS);

EID: 33750489727     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Jacobs MR, Palavecino E, Yomtovian R. Don't bug me: the problem of bacterial contamination of blood components - challenges and solutions. Transfusion 2001; 41:1331-4.
2. Palavecino E, Yomtovian R. Risk and prevention of transfusion-related sepsis. Curr Opin Hematol 2003; 10:434-9.
3. Sazama K. Bacteria in blood for transfusion. A review. Arch Pathol Lab Med 1994; 118:350-65.
4. Goodnough LT. Risks of blood transfusion. Crit Care Med 2003; 31:S678-86.
5. Yomtovian R, Lazarus HM, Goodnough LT, Hirschler NV, Morrissey AM, Jacobs MR. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993; 33:902-9.
6. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41:1493-9.
7. Dodd RY. Current viral risks of blood and blood products. Ann Med 2000; 32:469-74.
8. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18:195-204.
9. Palavecino E, Jacobs M, Yomtovian R. Bacterial contamination of blood products. Curr Hematol Rep 2004; 3:450-5.
10. Arendt A, Carmean J, Koch E, et al. Fatal bacterial infections associated with platelet transfusions - United States, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:168-70.
11. Yomtovian R, Palavecino E, Dykstra A, et al. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991-2004. Transfusion 2006; 46:719-730.
12. Filip DJ, Aster RH. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med 1978; 91:618-24.
13. Buchholz DH, Young VM, Friedman NR, Reilly JA, Mardiney MR, Jr. Detection and quantitation of bacteria in platelet products stored at ambient temperature. Transfusion 1973; 13:268-75.
14. Morrow JF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK. Septic reactions to platelet transfusions. A persistent problem. JAMA 1991; 266:555-8.
15. Yomtovian R. Bacterial contamination of blood: lessons from the past and road map for the future. Transfusion 2004; 44:450-60.
16. FDA. Center for Biologics Evaluation and Research (CBER). Substantially Equivalent 510(k) Device Information. http://www.fda.gov/cber/seltr/ k040086L.htm, March 15, 2005, and http://www.fda.gov/cber/510ksumm/ k040086s.htm, June 16, 2005.
17. Niu MT, Knippen M, Simmons L, Holness LG. Transfusion-transmitted Klebsiella pneumoniae fatalities, 1995 to 2004. Transfus Med Rev 2006; 20:149-157.
18. Sullivan MT, Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion 2005; 45:141-8.
19. Brecher ME, Hay SN, Rothenberg SJ. Monitoring of apheresis platelet bacterial contamination with an automated liquid culture system: a university experience. Transfusion 2003; 43:974-8.
20. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005; 88:93-7.
21. Munksgaard L, Albjerg L, Lillevang ST, Gahrn-Hansen B, Georgsen J. Detection of bacterial contamination of platelet components: six years' experience with the BacT/ALERT system. Transfusion 2004; 44:1166-73.
22. McDonald CP, Rogers A, Cox M, et al. Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med 2002; 12:303-9.
23. Nguyen KAT, Yamamoto T, Hirschler N, Validation of Pall bacterial detection system in a blood center setting. Transfusion 2003; 43(Suppl):S63-030K.
24. te Boekhorst PA, Beckers EA, Vos MC, Vermeij H, van Rhenen DJ. Clinical significance of bacteriologic screening in platelet concentrates. Transfusion 2005; 45:514-9.
25. Dykstra A, Jacobs M, Yomtovian R. Prospective microbiologic surveillance (PMS) of random donor (RDP) and single donor apheresis platelets (SDP). Transfusion 1998; 38:104S.
26. Perez P, Salmi LR, Follea G, et al. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion 2001; 41:862-72.
27. Rebibo D, Hauser L, Slimani A, Herve P, Andreu G. The French Haemovigilance System: organization and results for 2003. Transfus Apher Sci 2004; 31:145-53.
28. Stainsby D, Williamson L, Jones H, Cohen H. 6 Years of shot reporting - its influence on UK blood safety. Transfus Apher Sci 2004; 31:123-31.
29. Jacobs MR, Yomtovian R. Bacterial contamination of platelets: experience at University Hospitals of Cleveland 1991-2005. Presented at FDA. Slideset available at: http://origin.www.fda.gov/ohrms/dockets/ac/06/ slides/2006-4206OPH1_4.ppt. 2006.
30. AABB. Standards for blood banks and transfusion services. Bethesda, MD; AABB. 2004.
31. AABB. Guidance on implementation of new bacteria and reduction standard. Bulletin 04-07. Bethesda, MD. AABB. 2004.
32. College of American Pathologists. Commission on Laboratory Accreditation: Laboratory accreditation program: transfusion medicine checklist. http://www.cap.org/apps/docs/laboratoryc_accreditation/ checklists/transfusion_medicine_april2006.pdf. 2006.
33. College of American Pathologists. Statement to the U.S. Department of Health and Human Services Advisory Committee on Blood Safety and Availability. At: http://www.cap.org/apps/ cap.portal?_nfpb=true&cntvwrPtlt_actionOverride= %2Fportlets%2FcontentViewer%2Fshow&_windowLabel= cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D= advocacy%2Ftestimony%2Fblood_safety.html&_state= maximized&_pageLabel=cntvwr. 2004.
34. Wagner SJ, Robinette D, Friedman LI, Miripol J. Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria: an in vitro model. Transfusion 2000; 40:335-8.
35. de Korte D, Marcelis JH, Verhoeven AJ, Soeterboek AM. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang 2002; 83:13-6.
36. Ness P, Braine H, King K, et al. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001; 41:857-61.
37. Bell CE, Botteman MF, Gao X, et al. Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States. Clin Ther 2003; 25:2464-86.
38. Corash L. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates. Vox Sang 2000; 78 Suppl 2:205-10.
39. Anonymous. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59. BioDrugs 2003; 17:66-8.
40. Simonsen AC, Johansson PI, Conlan MG, et al. Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study. Transfusion 2006; 46:424-33.
41. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang 2000; 78 Suppl 2:211-5.
42. Palavecino E, Jacobs MR, Goodrich RP, McBurney LL, Goodrich TB, Yomtovian R. Photochemical decontamination of bacteria: Analysis of log and stationary growth phases (abstract). Transfusion 2001; 41(Suppl):88S.
43. BacT/ALERT® BPA (43-03171) and BPN (43-03191) Product Inserts, May 2004.
44. Shanholtzer CJ, Schaper PJ, Peterson LR. Concentrated gram stain smears prepared with a cytospin centrifuge. J Clin Microbiol 1982; 16:1052-6.
45. Lauer BA, Reller LB, Mirrett S. Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens. J Clin Microbiol 1981; 14:201-5.
46. Burstain JM, Brecher ME, Workman K, Foster M, Faber GH, Mair D. Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism. Transfusion 1997; 37:255-8.
47. Werch JB, Mhawech P, Stager CE, Banez EI, Lichtiger B. Detecting bacteria in platelet concentrates by use of reagent strips. Transfusion 2002; 42:1027-31.
48. Hay SN, Brecher ME. Validation of pH and glucose determination for bacteria detection screening in platelet concentrates stored in the Terumo Teruflex XT612 platelet container. Transfusion 2004; 44:1395.
49. Yaser MH, Triulzi DJ. Use of a pH meter for bacterial screening of whole blood platelets. Transfusion 2005; 45:1133-7.
50. Yomtovian R, Pokorny MA, Downes KA. Application of pH testing for bacterial detection of platelets: a plea for standardization (abstract). Transfusion 2004; 44(Suppl):S77-040E.
51. FDA. Advisory Committee on Blood Safety and Availability. Presentation by Silva, M. Current status of bacterial detection in platelet concentrates, availability and progress toward seven day platelets, January 25-26. Available at: http://www.hhs.gov/bloodsafety/ presentations/jan2005.html. 2005.
52. Yomtovian R, Brecher ME. pH and glucose testing of single-donor apheresis platelets should be discontinued in favor of a more sensitive detection method. Transfusion 2005; 45:646-8.
53. Rock G, Neurath D, Toye B, et al. The use of a bacteria detection system to evaluate bacterial contamination in PLT concentrates. Transfusion 2004; 44:337-42.
54. Castro E, Bueno JL, Barea L, Gonzalez R. Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine. Transfus Med 2005; 15:185-95.
55. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005; 45:1845-52.
56. Easley S, Jacobs M, Pokorny M, Hendrix D, Bajaksouzian S, Yomtovian R. Development and application of proficiency testing (PT) for platelet bacterial contamination (PBC). Poster presentation (SE) at American Association of Blood Banks, Seattle, WA, October 2005 (abstract). Transfusion 2005; 45:53A.
57. Hundhausen T, Muller TH. False-positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new-generation plastic bottles: a multicenter pilot study. Transfusion 2005; 45:1267-74.
58. Holme S, McAlister MB, Ortolano GA, et al. Enhancement of a culture-based bacterial detection system (eBDS) for platelet products based on measurement of oxygen consumption. Transfusion 2005; 45:984-93.
59. Fournier-Wirth C, Deschaseaux M, Defer C, et al. Evaluation of the enhanced bacterial detection system for screening of contaminated platelets. Transfusion 2006; 46:220-4.
60. Jacobs MR, Bajaksouzian S, Windau A, Palavecino EL, Yomtovian R. Evaluation of the Scansystem method for detection of bacterially contaminated platelets. Transfusion 2005; 45:265-9.
61. McDonald CP, Colvin J, Robbins S, Barbara JA. Use of a solid-phase fluorescent cytometric technique for the detection of bacteria in platelet concentrates. Transfus Med 2005; 15:175-83.
62. Weinstein RJ, Young LS. Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors. J Clin Invest 1976; 58:190-9.
63. Sanz C, Pereira A, Vila J, Faundez AI, Gomez J, Ordinas A. Growth of bacteria in platelet concentrates obtained from whole blood stored for 16 hours at 22 degrees C before component preparation. Transfusion 1997; 37:251-4.
64. Schmidt M, Weis C, Heck J, et al. Optimized Scansystem platelet kit for bacterial detection with enhanced sensitivity: detection within 24 h after spiking. Vox Sang 2005; 89:135-9.
65. Dunne WM, Jr., Case LK, Isgriggs L, Lublin DM. In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates. Transfusion 2005; 45:1138-42.
66. AuBuchon JP, Cooper LK, Leach MF, Zuaro DE, Schwartzman JD. Experience with universal bacterial culturing to detect contamination of apheresis platelet units in a hospital transfusion service. Transfusion 2002; 42:855-61.
67. AABB. Guidance on management of blood and platelet donors with positive or abnormal results on bacterial contamination tests (Supplements 04-07). Bulletin 05-02, Bethesda, MD: AABB. 2005.
68. Gilligan PH. Impact of clinical practice guidelines on the clinical microbiology laboratory. J Clin Microbiol 2004; 42:1391-5.
69. Heddle NM, Cook RJ, Blajchman MA, et al. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial. Transfusion 2005; 45:896-903.
70. Sweeney JD, Kouttab NM, Holme S, Kurtis JD, Cheves TA, Nelson EJ. Prestorage pooled whole-blood-derived leukoreduced platelets stored for seven days preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction. Transfusion 2004; 44:1212-9.
71. FDA. Center for Biologics Evaluation and Research (CBER). Substantially Equivalent 510(k) Device Information. http://www.fda.gov/cber/seltr/ k040086L.htm, January 26, 2006, updated February 7, 2006.
72. Liu HW, Yuen KY, Cheng TS, et al. Reduction of platelet transfusion-associated sepsis by short-term bacterial culture. Vox Sang 1999; 77:1-5.
73. Ramirez-Arcos S, Goldman M. Evaluation of pooled cultures for bacterial detection in whole blood-derived platelets. Transfusion 2005; 45:1275-9.
74. Brecher ME, Hay SN, Rose AD, Rothenberg SJ. Evaluation of BacT/ALERT plastic culture bottles for use in testing pooled whole blood-derived leukoreduced platelet-rich plasma platelets with a single contaminated unit. Transfusion 2005; 45:1512-7.
75. Brecher ME, Hogan JJ, Boothe G, et al. Platelet bacterial contamination and the use of a chemiluminescence-linked universal bacterial ribosomal RNA gene probe. Transfusion 1994; 34:750-5.
76. Dreier J, Stormer M, Kleesiek K. Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates. J Clin Microbiol 2004; 42: 4759-64.
77. GenPrime. Innovations for a secure and healthy world. Presented to FDA, slideshow available at: http://www.fda.gov/ohrms/dockets/ac/06/slides/ 2006-4206OPH1_7_files/frame.htm. 2006.
78. SUBC I. Rapid Bacterial Detection System: Fully Automated 4 minute CFU/ ml response system. Presented to FDA, slideshow available at: http://origin.www.fda.gov/ohrms/dockets/ac/06/slides/2006-4206OPH1_2.ppt. 2006.
79. Verax Biomedical Incorporated. Verax Biomedical platelet PGD test. Presented to FDA, slideshow available at: http://www.fda.gov/ohrms/ dockets/ac/06/slides/2006-4206-OPH1_3_files/frame.htm. 2006.
80. BCR Diagnostics. Bacteriological biosensor for rapid screening of platelets shortly before transfusion. Presented to FDA, slideshow available at: http://www.fda.gov/ohrms/dockets/ac/06/slides/ 2006-4206OPH1_6_files/frame.htm.
81. Kirby C, Beausang L, Kovalenko V, Levin A. BacTx - A rapid assay for the detection of bacteria in platelet units. Annual Meeting, American Association of Blood Banks, Abstract SP74. 2005.